Lesson of the month 1: Pericardial mass and cardiac tamponade associated with Mycoplasma pneumoniae Mycoplasma pneumoniae primarily causes respiratory tract infections. Extrapulmonary manifestations are seen in 20-25% of cases. Cardiac involvement is rarely reported. We present a unique case of a pericardial mass and cardiac tamponade associated with a Mycoplasma pneumoniae pneumonia. This required emergency pericardial fenestration. The patient improved dramatically postoperatively on antibiotics and there was no recurrence of the pericardial effusion on follow up. This case highlights the often forgotten invasive properties of a common respiratory tract pathogen and emphasises the need to consider this easily treatable entity in the differential diagnosis of idiopathic pericardial effusions.
Lesson
A 40-year-old African-Caribbean woman presented to the emergency department with a 4-day history of worsening shortness of breath and chest pain. These were preceded by a 3-week history of fevers, a non-productive cough, fatigue and generalised aches. Signifi cant medical history included childhood asthma and a 10-pack-year smoking history. She was not prescribed any regular medication.
Initial clinical examination revealed a temperature of 38.5°C, a blood pressure of 107/85 mmHg, a heart rate of 110 beats/min and a respiratory rate of 20 breaths/min, with oxygen saturations of 95% on room air. Heart sounds were normal on auscultation and there was evidence of bronchial breathing on the right lung base with a few bibasal crepitations. Systemic examination did not reveal any other abnormalities. Electrocardiogram (ECG) showed sinus rhythm with a ventricular rate of 102. There was a fi xed anterolateral T-wave inversion with good R-wave progression. The P-R interval was 146 ms with a QTc of 427 ms. The axis was normal with no evidence of fascicular block. The chest radiograph revealed an enlarged, globular, cardiac silhouette with right basal consolidation in the lung parenchyma. Laboratory blood tests during the course of her admission are summarised in Table 1 . Mycoplasma serology was positive. A transthoracic echocardiogram was performed. This showed a moderate pericardial effusion with a mass in the pericardial space compressing the right ventricle. Respiratory variation of Doppler velocities across the mitral and tricuspid valve suggested tamponade. Collapse of the inferior vena cava during inspiration was impaired. Left ventricular size and function were normal (Fig 1) .
The patient's computed tomography (CT) scan of the chest/abdomen/pelvis confi rmed a small, right-sided, pleural effusion with right basal consolidation. A large pericardial effusion was noted and there was an anterior mediastinal soft-tissue mass by the right lower lobe and pulmonary artery.
The patient was transferred to a tertiary centre for further investigations and drainage of the pericardial fl uid. Subsequent cardiac magnetic resonance imaging (MRI) showed a large pericardial effusion with a mass in the pericardial space. There was also a mass posterior to the left atrium, which suggested a benign bronchial cyst.
The patient underwent a right-sided, video-assisted, thoracoscopic pericardial window using pericardial fenestration. A volume of 800 ml pericardial fl uid was drained and the pericardial mass was biopsied. Samples were sent for microbiology and histology.
The pericardial fl uid was negative for acid-fast bacilli and fungal cultures. The pericardial biopsy demonstrated chronically infl amed pericardial tissue. Biopsy of the pericardial mass revealed an organising thrombus.
The patient was treated with amoxicillin and clavulanate (Augmentin), and clarithromycin. She made an excellent clinical recovery and her infl ammatory markers returned to normal.
Subsequent follow-up echocardiography showed no residual pericardial effusion, normal left ventricular function and no evidence of valvular abnormalities (Fig 2) .
Repeat cardiac MRI, 4 months post-pericardial drainage and biopsy, demonstrated complete resolution of the pericardial disease. The benign looking posterior mediastinal cyst is estimated at 4.5% in people with serological evidence of infection. It is more common in adults and has been reported in isolated cases, manifesting largely as myopericarditis. 2, 3 Proposed hypotheses for M pneumonia-associated carditis include direct invasion of the myocardium by the organism (via the lymphatics, circulation or contamination from the lower respiratory tract), autoimmune mechanisms or increased tendency for intravascular coagulation. 4 The present case is a unique example of a plausible association between M pneumoniae and a pericardial mass and effusion, causing cardiac tamponade. It highlights the often forgotten invasive properties of a common respiratory tract pathogen, and emphasises the need to consider this easily treatable entity in the differential diagnosis of idiopathic pericardial effusions. ■ remained unchanged from the previous scan. The left and right ventricular cavity sizes and function were normal. Myocardial tissue characterisation was also normal.
Discussion
Mycoplasma pneumoniae is a common cause of atypical pneumonia in young adults. Extrapulmonary manifestations are seen in 20-25% of cases and may appear before or after, or coexist with, the pulmonary disease. 1 Although extrapulmonary manifestations of M pneumoniae are well described, cardiac tamponade and pericardial masses associated with M pneumonia are rarely reported.
Cardiac complications associated with M pneumoniae are relatively uncommon. The incidence of cardiac involvement Pericardial biopsy Chronic inflammation ACE = angiotensin-converting enzyme; AFB = acid-fast bacillus; ANA = antinuclear antibody; ANCA = anti-neutrophil cytoplasmic antibody; CRP = C-reactive protein; ENA = extractable nuclear antigen; WCC = white cell count.
Key points
> Mycoplasma pneumoniae is a common respiratory pathogen that can cause signifi cant cardiac complications, including pericardial mass and cardiac tamponade > This easily treatable entity should be considered in the differential diagnosis of idiopathic pericardial effusions
Introduction
Patients with current or past hepatitis B virus (HBV) infection are at risk of viral reactivation if they receive immune-modulating treatment or chemotherapy. This can range from subclinical elevation in HBV DNA levels to abnormal liver function tests (LFTs), to severe hepatitis with liver failure and risk of death.
ABSTRACT Case report
A 72-year-old man was noted to have submandibular gland swelling at a dental appointment. Further assessment showed widespread lymphadenopathy and excision biopsy diagnosed diffuse large B-cell lymphoma. His past medical history included pulmonary embolus. He was planned for six cycles of R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin [hydroxydaunomycin], vincristine, prednisolone). Before starting treatment, hepatitis B serology was checked; he was anti-HBcAb (hepatitis B core antibody) positive, HBsAg (hepatitis B surface antigen) negative, anti-HBsAb (hepatitis B surface antibody) negative with undetectable HBV DNA (<20 IU/ml), in keeping with past HBV infection. LFTs were normal. The virology report stated: 'consistent with past HBV infection, but risk of reactivation on immunosuppression. Please ensure HBsAg and LFTs are monitored. ' After four cycles of R-CHOP (January 2013), tests for HBsAg were positive and HBV DNA was 1.2' 10 7 IU/ml, consistent with acute HBV reactivation. The patient was started on tenofovir 245 mg daily.
He completed six cycles in March 2013 and positron emission tomography computed tomography (PET-CT) confi rmed good radiological response. However, in May 2013 he was admitted with jaundice and international normalised ratio (INR) >10. Blood tests showed signifi cant liver dysfunction (bilirubin 105 µmol/l, alanine aminotransferase [ALT] 988 U/l, alkaline phosphatase [ALP] 317 U/l and albumin 35 g/l). HBV DNA had fallen to 5,300 IU/ml. An abdominal CT scan showed no biliary obstruction or other cause for jaundice. Tests for other hepatotrophic viruses were negative. Transjugular liver biopsy showed markedly cholestatic hepatitis (modifi ed histology activity index [HAI] infl ammatory grade 9/18 and fi brosis
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